Schott Pharma
Price
Price
CHART BY
Historical dividends and forecast
Schott Pharma has so far distributed $0.163 in 2024. The next dividend will be paid on 07.02.2025
CHART BY
Frequently asked questions
What is Schott Pharma's market capitalization?
What is Schott Pharma's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Schott Pharma?
What are the analyst ratings and target price for Schott Pharma's stock?
What is Schott Pharma's revenue over the trailing twelve months?
Is Schott Pharma paying dividends?
What is the EBITDA for Schott Pharma?
What is the free cash flow of Schott Pharma?
How many employees does Schott Pharma have, and what sector and industry does it belong to?
What is the free float of Schott Pharma's shares?
Financials
- Market Cap
- $3.82B
- EPS (TTM)
- $1.037
- Free Float
- 27.13M
- P/E ratio (TTM)
- 24.47
- Revenue (TTM)
- $998.27M
- EBITDA (TTM)
- $248.60M
- Free Cashflow (TTM)
- $83.70M
Pricing
- 1D span
- $23.57$25.46
- 52W span
- $23.46$47.04
Analyst Ratings
The price target is $33.39 and the stock is covered by 11 analysts.
Buy
4
Hold
7
Sell
0
Information
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. It operates through the Drug Containment Solutions and Drug Delivery Systems segments. The Drug Containment Solutions segment focuses on the products from the Core category that currently make up the largest part of the DCS product portfolio. The Drug Delivery Systems segment includes products that are characterized by improved product functionality and belong to the HVS product portfolio. It offers a wide range of advanced drug containment solutions and delivery systems for inject able drugs that supply to the pharmaceutical and biotechnology industries. The company was founded on May 10, 2022 and is headquartered in Mainz, Germany.
- Employees
- 4,689
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- DE000A3ENQ51
- Primary Ticker
- 1SXP